Document is current
Any future updates will be listed below
-
Authors
Song, No-Joon
Allen, Carter
Vilgelm, Anna E.
Riesenberg, Brian P.
Weller, Kevin P.
Reynolds, Kelsi
Chakravarthy, Karthik B.
Kumar, Amrendra
Khatiwada, Aastha
Sun, Zequn
Ma, Anjun
Chang, Yuzhou
Yusuf, Mohamed
Li, Anqi
Zeng, Cong
Evans, John P.
Bucci, Donna
Gunasena, Manuja
Xu, Menglin
Liyanage, Namal P. M.
Bolyard, Chelsea
Velegraki, Maria
Liu, Shan-Lu
Ma, Qin
Devenport, Martin
Liu, Yang
Zheng, Pan
Malvestutto, Carlos D.
Chung, Dongjun
Li, Zihai http://orcid.org/0000-0003-4603-927X
-
Funding
Funding for this research was provided by:
National Institute of Allergy and Infectious Diseases (R01AI077283)
National Cancer Institute (R01CA213290, R37CA233770, P30CA016058)
- License Information
-
More Information
Article History
Received: 15 November 2021
Accepted: 18 December 2021
First Online: 10 January 2022
Declarations
:
: This study included samples from patients enrolled in NCT04317040 at The Ohio State University Wexner Medical Center. Written or witnessed oral informed consent was obtained for each patient. This trial and protocol were approved by Western Institutional Review Board. The study was monitored continuously by a clinical monitor and a medical monitor from the contract research organization (CRO) who also generated safety reports submitted to an independent Data and Safety Monitoring Board (DSMB). Data quality control checks were performed and the medical monitor verified that the clinical trial was conducted, and data were generated in compliance with the protocol, International Conference on Harmonization Good Clinical Practice (ICH GCP), and all applicable regulatory requirements.
: Not applicable.
: The authors declare that they have no competing interests.
